Sequent Scientific Limited has informed the Exchange about Schedule of meet
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sequent Scientific Limited has scheduled a conference call with analysts and investors on Monday, August 11, 2025, at 9:00 AM IST to discuss its Q1FY26 financial results. The call will be addressed by MD & CEO Rajaram Narayanan, CFO Saurav Bhala, along with Dr. Hari Babu Bodepudi (WTD & CEO) and Ramakant Singani (CFO) from Viyash Lifesciences. The intimation has been filed with BSE and NSE under Regulation 30 of SEBI's Listing Regulations. Dial-in details have been enclosed and are also available on the company's website at www.sequent.in.
This is a routine disclosure ahead of quarterly results and typically has no immediate effect on the stock price. Investors should watch the actual Q1FY26 numbers and management commentary on the call for any meaningful direction.